STAGE II BLADDER CANCER AJCC V8
Clinical trials for STAGE II BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Bladder-Sparing combo shows promise in fighting aggressive cancer
Disease control Recruiting nowThis study tests a combination of two drugs (enfortumab vedotin and pembrolizumab) plus radiation therapy for people with muscle invasive bladder cancer. The goal is to destroy the tumor without removing the bladder, offering an alternative to standard surgery. About 47 adults wi…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
New drug combo offers hope for bladder cancer patients who Can't take chemo
Disease control Recruiting nowThis study tests whether combining futibatinib and durvalumab before bladder removal surgery can help patients with muscle-invasive bladder cancer who cannot receive standard cisplatin chemotherapy. About 24 adults with a specific genetic marker (FGFR overexpression) will receive…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Can fewer radiation blasts beat bladder cancer just as well?
Disease control Recruiting nowThis study compares two ways of giving radiation therapy for muscle-invasive bladder cancer. One group gets the usual number of radiation sessions (hypofractionation) and the other gets even fewer, higher-dose sessions (ultra-hypofractionation), both combined with standard chemot…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Bladder-Sparing combo shows promise in avoiding surgery
Disease control Recruiting nowThis study tests whether giving the immunotherapy drug pembrolizumab along with radiation therapy after chemotherapy can help people with muscle invasive bladder cancer keep their bladder instead of having it surgically removed. About 111 participants will receive this combinatio…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC